ADF

(redirected from Abuse-Deterrent Formulations)
Category filter:
AcronymDefinition
ADFAutomatic Direction Finder/Finding
ADFAlliance Defense Fund
ADFAustralian Defence Force
ADFApplication Development Framework
ADFAcid Detergent Fiber
ADFAutomatic Direction Finder (US DoD)
ADFAustralian Drug Foundation
ADFAssemblée des Départements de France (French: Departments Assembly France)
ADFAmerican Dance Festival
ADFÁr Ndraíocht Féin (Our Own Druidism)
ADFAlternate Day Fasting (dieting)
ADFAsian Dub Foundation
ADFA Druid Fellowship
ADFAfrican Development Fund
ADFAugmented Dickey-Fuller (economics)
ADFAfrican Development Forum
ADFAuto-Darkening Filter (glass)
ADFAdvanced Differential Fabric
ADFAdministration Configuration File
ADFAudio File
ADFAutomatic Document Feeder
ADFAdd Floating
ADFAlarm Distribution Frame
ADFAutomocion Diseno Y Fabricacion
ADFAutomatic Direction Finder
ADFAgent Developing Framework
ADFAcronym Database File
ADFAdapter Description File
ADFAutomated Document Factory
ADFAbuse-Deterrent Formulations (opiod abuse)
ADFAfrican Development Foundation
ADFAllied Democratic Forces (Ugandan insurgents)
ADFAutomatic Document Feed(er)
ADFArbeitskreis Digitale Fotografie (German: Working Group on Digital Photography)
ADFAssociation Dentaire Française (French Dental Association)
ADFAfrican dwarf frog
ADFAeroporto Di Firenze (Firenze, Italy)
ADFAmerica's Development Foundation
ADFApproved Deposit Fund (Australia)
ADFA Diversified Family (est. 2000)
ADFAverage Daily Flow
ADFAlternative Display Facility (NASD)
ADFAir Defense Force
ADFAutomotive Distribution Federation (UK)
ADFAir Defense Fighter
ADFAmiga Disk File
ADFAnnular Dark-Field
ADFAdvanced Dominance Fighter (aircraft; Gründer Industries)
ADFArbeitsgemeinschaft Dermatologische Forschung (German Society of Experimental Dermatology)
ADFAnglican Development Fund (est. 1967; Australia)
ADFAssociation des Francophones (French: Association of French Speakers)
ADFAdvance Disposal Fee (Florida)
ADFAccess Control Decision Function
ADFAirline Dispatchers Federation
ADFAlbanian Development Fund (Tirana, Albania)
ADFAutomatically Defined Function
ADFApplication Development Facility
ADFAmsterdam Density Functional package
ADFAuto da Fé (band)
ADFArkansas Defense Force
ADFAstrophysics Data Facility
ADFApplication Descriptor File
ADFAvian Development Facility (space station scientific payload; part of the Space Station Biological Research Project)
ADFAerospace Data Facility (USAF)
ADFAirport Duty Free
ADFAmericas Duty Free (publication: Global Marketing Company Ltd.)
ADFAsymptotic Distribution Free
ADFAustralian Doctors' Fund
ADFAverage Duration of Fades
ADFAirborne Direction Finder
ADFAncillary Data Flag
ADFAfter Deducting Freight
ADFAdvanced Distribution Frame (Telect Inc.)
ADFAdd-Drop Filter
ADFAmerican Dancewheels Foundation, Inc. (Bala Cynwyd, PA)
ADFAusbildungsdienst der Formation (Swiss Army)
ADFAnalyse, Développement, Formation (French: Analysis, Development, Training; software development company)
ADFApplication Dependent Format
ADFAirborne Direction-Finding
ADFAuxiliary Detonating Fuze
ADFAdvisory File
ADFAvionics Development Facility
ADFAmplitude Density Function (the probability density of surface height)
ADFAcademy of Dance on Film (Hollywood, California)
ADFAmplify-Decode-and-Forward (protocol)
ADFArgentine Society of Cinematographers
ADFAdministrator's Discretionary Fund
ADFAdditional Deposit Fund (insurance)
ADFAdvanced Development Facility
ADFAddress Decoder Fault
ADFAkuapem Development Foundation (Ghana)
ADFArmy Declassification Facility
ADFArea Delimitation File
ADFAlarm Distribution Frame (Sprint)
ADFAllocation and Distribution of Fires
ADFActivity Address File (claims)
ADFAlveolar Dead Space Fraction
ADFApply Directly to Forehead (band)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
The rising prevalence of cancer, high demand for pain therapeutics in the treatment of chronic pain, regulatory approvals & launches of innovative drug formulations, and increasing approval rate of abuse-deterrent formulations of opioid drugs are major driving factors of the global opioids drugs market.
presented a poster describing an approach to the evaluation of opioid comparators when assessing the effectiveness of abuse-deterrent formulations (ADFs) of extended-release opioids at the College on Problems of Drug Dependence (CPDD) 81st Annual Scientific Meeting in San Antonio, Texas.
Ashworth has around two decades of experience in the development of novel analgesics and abuse-deterrent formulations. While at Grunenthal GmbH, she led the clinical team during the EU and US regulatory submission and approval of tapentadol and most recently was head of its EU Innovative Medicines Unit hub in Leiden, Netherlands.
Founded in 1989, Inflexxion's data analytics division includes the National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO) to better understand prescription opioid and stimulant use and the effectiveness of abuse-deterrent formulations (ADF).
In November, the agency released a 30-page guidance document formally defining "abuse-deterrent formulations" (ADFs).
While there continues to be a need for expanding capabilities for specialized dosage forms such as modified-release, pediatric-geriatric, and abuse-deterrent formulations, another growth opportunity for CDMOs, according to Ms.
Abuse-deterrent formulations (ADFs) are designed to provide pain relief while deterring common methods of manipulation and reducing the potential for nonoral abuse and misuse.
To help prevent abuse, drug manufacturers have come up with abuse-deterrent formulations (ADFs).
Murthy also urged pharmaceutical companies to continue developing abuse-deterrent formulations of opioids, and to prioritize development of nonopioid alternatives for pain relief.
He also wanted to remove $75 million in incentives to drug companies for "abuse-deterrent formulations" - drugs that are more difficult to crush and snort - and instead use the money for low-income, pregnant women seeking treatment for addiction.
The FDA will convene an advisory committee meeting on May 3 to May 4 to discuss the impact of boxed warnings for extended-release opioids and approvals of abuse-deterrent formulations, Dr.